Locally advanced or metastatic NSCLC
Clinical trials for Locally advanced or metastatic NSCLC explained in plain language.
Never miss a new study
Get alerted when new Locally advanced or metastatic NSCLC trials appear
Sign up with your email to follow new studies for Locally advanced or metastatic NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer pill targets resistant mutations in early trial
Disease control Recruiting nowThis Phase 1 study tests a new daily pill called HS-10504 in 230 people with advanced non-small cell lung cancer that has a specific genetic change (EGFR C797S mutation) and has stopped responding to earlier treatments. The main goal is to find the safest dose and check for side …
Matched conditions: LOCALLY ADVANCED OR METASTATIC NSCLC
Phase 1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a Two-Drug combo outsmart resistant lung cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether a combination of two targeted drugs, ASKC202 and limertinib, can help people with advanced non-small cell lung cancer (NSCLC) whose tumors have a specific genetic change (MET amplification/overexpression) and have stopped responding to earlie…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NSCLC
Phase 3 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC